Cita APA

Lu, H., Yang, Y., Gad, E., Inatsuka, C., Wenner, C. A., Disis, M. L., & Standish, L. J. (2011). TLR2 agonist PSK activates human NK cells and enhances the anti-tumor effect of HER2-targeted monoclonal antibody therapy.

Citación estilo Chicago

Lu, Hailing, Yi Yang, Ekram Gad, Carol Inatsuka, Cynthia A. Wenner, Mary L. Disis, y Leanna J. Standish. TLR2 Agonist PSK Activates Human NK Cells and Enhances the Anti-tumor Effect of HER2-targeted Monoclonal Antibody Therapy. 2011.

Cita MLA

Lu, Hailing, et al. TLR2 Agonist PSK Activates Human NK Cells and Enhances the Anti-tumor Effect of HER2-targeted Monoclonal Antibody Therapy. 2011.